Germany has not fully realised its biosimilar potential

29 September 2020 - Investigators have concluded that fully realizing the cost-saving potential of biosimilars could “release enormous resources” for ...

Read more →

Mylan, Lupin launch etanercept biosimilar in Germany

26 August 2020 - The launch marks the first European market entry for Nepexto. ...

Read more →

German health minister calls for faster adoption of biosimilar drugs

14 November 2018 - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs ...

Read more →